The Importance of Specific Gamma-carboxyglutamic Acid Residues in Prothrombin. Evaluation by Site-specific Mutagenesis
Overview
Authors
Affiliations
Prothrombin has 10 gamma-carboxyglutamic acid residues which are essential for the metal ion binding properties and membrane binding function of the protein. To assess the importance of each gamma-carboxyglutamic acid residue we made, by site directed mutagenesis, a series of mutant human prothrombins each with a single glutamic acid to aspartic acid substitution at positions 6, 7, 14, 16, 19, 20, 25, 26, 29, or 32 which are gamma-carboxylated in native prothrombin. Along with wild-type prothrombin, the prothrombin mutants were expressed in Chinese hamster ovary cells, purified by immunoaffinity chromatography using polyclonal anti-prothrombin antibodies, and shown by amino acid analysis to contain the expected number of gamma-carboxyglutamic acid residues. Only substitution of gamma-carboxyglutamic acid 6 with aspartic acid yields a protein with procoagulant activity, affinity for phospholipid and KM(app) for prothrombinase indistinguishable from wild-type prothrombin. In contrast, the conservative gamma-carboxyglutamic acid to aspartic acid mutation at positions 16, 26, or 29 results in proteins with little or no procoagulant activity, Kd(app) for binding to phospholipid at least 200-fold higher than wild-type prothrombin and a KM(app) for interaction with the prothrombinase complex nearly 100-fold higher than wild-type prothrombin. The mutations at residues 7, 14, 19, 20, 25, or 32 yielded proteins with intermediate procoagulant activities, between 15 and 52% of wild-type prothrombin. These data have been interpreted to suggest that there are certain gamma-carboxyglutamic acid residues which are important to maintaining the basic structure of the calcium-liganded Gla domain while other gamma-carboxyglutamic acid residues subserve other functions including membrane binding and interdomain interactions.
Singh D, Basit A, Rettie A, Alade N, Thummel K, Prasad B Anal Chim Acta. 2023; 1284:341972.
PMID: 37996163 PMC: 10789187. DOI: 10.1016/j.aca.2023.341972.
Rishavy M, Hallgren K, Wilson L, Hiznay J, Runge K, Berkner K Blood. 2022; 140(15):1710-1722.
PMID: 35767717 PMC: 9707401. DOI: 10.1182/blood.2021014275.
Berkner K, Runge K Int J Mol Sci. 2022; 23(10).
PMID: 35628569 PMC: 9146348. DOI: 10.3390/ijms23105759.
Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma.
Yang Y, Li G, Lu Z, Liu Y, Kong J, Liu J Front Oncol. 2021; 11:726213.
PMID: 34900676 PMC: 8660097. DOI: 10.3389/fonc.2021.726213.
Basit A, Prasad B, Estergreen J, Sabath D, Alade N, Veenstra D Clin Transl Sci. 2020; 13(4):718-726.
PMID: 32004415 PMC: 7359935. DOI: 10.1111/cts.12757.